← SynDRA
OMAPATRILAT
SynDRA canonical compound SYN0002096 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ACE | MME |
|---|
| Mechanism of action | metalloproteinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- metalloproteinase inhibitor
- MME MODULATOR
- SLC33A1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
- Vasopeptidase Inhibitors
Cross-references
Synonyms
- BMS-186716
- Omapatrilate
- BMS-186716-01
- Omapatrilat (JAN/USAN/INN)
- (4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid
- Bms 186716
- Vanlev
- omapatrilatum
- RefChem:856761
- DTXCID4090764
- Omapatrilat [USAN]
- omapatrylate
- UNII-36NLI90E7T
- Omapatrilat [USAN:INN:BAN]
- FT8
- OMAPATRILAT [MI]
- OMAPATRILAT [INN]
- OMAPATRILAT [JAN]
- OMAPATRILAT [VANDF]
- OMAPATRILAT [MART.]
- OMAPATRILAT [WHO-DD]
- SCHEMBL130098
- orb1706879
- Omapatrilat, >=98% (HPLC)
- CHEBI:135660
- GLXC-22404
- SGA30500
- BDBM50073120
- AKOS040742333
- CS-6369
- NCGC00509984-01
- DA-66337
- HY-18208
- MS-27025
- NS00069248
- D01970
- G12899
- T16385
Look up OMAPATRILAT in the interactive SynDRA portal →